Molly B. Moravek

ORCID: 0000-0001-9972-4938 · 11 papers in corpus
observational 2026
Frontiers in reproductive health ·doi:10.3389/frph.2026.1918673

INTRODUCTION: Retained products of conception (rPOC) are a common complication following early pregnancy loss (EPL) and may contribute to infertility and delays in subsequent fertility treatment. Oral contraceptive pills (OCPs) are frequent…

2023
·doi:10.1007/978-3-031-14881-1_29
observational 2022
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.14162

ObjectiveTo determine the implications of an incidentally noted subchorionic hematoma on pregnancy outcomes in the infertile population.MethodsRetrospective cohort study at a tertiary care, university-based facility. All patients with intra…

review 2020
Endocrinology ·doi:10.1210/endocr/bqaa014

Studies show that a subset of transgender men desire children; however, there is a paucity of literature on the effect of gender-affirming testosterone therapy on reproductive function. In this manuscript, we will review the process of gend…

2017
·doi:10.1007/978-3-319-17798-4_29
observational 2016

Objective. Many women with endometriosis experience significant delay between the onset of symptoms and definitive diagnosis. Much is published on physician awareness of endometriosis and on the experiences of women with the condition. Ther…

2016
·doi:10.1007/978-3-319-17002-2_29-1
observational 2010
Acta obstetricia et gynecologica Scandinavica ·doi:10.3109/00016341003657900

OBJECTIVE: Many women with endometriosis experience significant delay between the onset of symptoms and definitive diagnosis. Much is published on physician awareness of endometriosis and on the experiences of women with the condition. Ther…

2010
nonrandomized-trial 2009
Gynecologic and obstetric investigation ·doi:10.1159/000230713

BACKGROUND: Current medical therapies for endometriosis result in delayed conception and have not been shown to provide any fertile benefit subsequent to treatment. Thiazolidinediones (TZDs) do not impede conception and have been shown to r…

2008
·doi:10.1016/j.fertnstert.2008.07.237